Average Co-Inventor Count = 6.25
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (17 from 3,685 patents)
17 patents:
1. 12049503 - Treatment of LAG-3 positive tumors
2. 11807686 - Treatment of LAG-3 positive tumors
3. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
4. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
5. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
6. 10323092 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
7. 10323093 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
8. 10316090 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
9. 10316091 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
10. 10308714 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
11. 10266594 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
12. 10266595 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
13. 10266596 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
14. 10138299 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
15. 10072082 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling